1,1100
29-ноября-24 12:45:00
15 мин. задержка
Акции
+0,0600
+5,71%
Сегодняшний диапазон
1,0500 - 1,1100
ISIN
N/A
Источник
NASDAQ
Ocuphire to Participate in the 2021 BIO CEO & Investor Conference and Cantor Fitzgerald’s Panel on Eyeing Key Events in the Ophthalmology Space in 2021
11 фев 2021 08:12:54 Источник Nasdaq GlobeNewswire
Ocuphire Announces Publication of ORION-1 Phase 2 Results for Nyxol in Clinical Ophthalmology and Presentation at the January OIS Presbyopia Innovation Showcase
20 янв 2021 06:00:00 Источник Nasdaq GlobeNewswire
Ocuphire Completes Enrollment in MIRA-2 Phase 3 Clinical Trial Investigating Nyxol® for Reversal of Mydriasis
06 янв 2021 06:00:01 Источник Nasdaq GlobeNewswire